Clinical Trial Update: Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the bioequivalence of Metronidazole Gel 0.75% for bacterial vaginosis. The study has completed (Phases 1 and 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Vaginosis

Drugs mentioned

• Metronidazole Gel 0.75% (Metronidazole)

Snippet

Sponsor: Teva Pharmaceuticals USA | Conditions: Bacterial Vaginosis | Phase 1, Phase 2 | Status: COMPLETED